Semi-Annual Consolidated Statement Of Cash Flows

TOWA PHARMACEUTICAL CO.,LTD. - Filing #7297738

Concept As at
2024-09-30
2024-04-01 to
2024-09-30
As at
2024-03-31
As at
2023-09-30
2023-04-01 to
2023-09-30
As at
2023-03-31
Semi-annual consolidated statement of cash flows
Statement of cash flows
Cash flows from operating activities
Subtotal
16,461,000,000 JPY
-4,252,000,000 JPY
Interest and dividends received
124,000,000 JPY
27,000,000 JPY
Interest paid
-720,000,000 JPY
-399,000,000 JPY
Net cash provided by (used in) operating activities
8,654,000,000 JPY
-4,524,000,000 JPY
Cash flows from investing activities
Purchase of property, plant and equipment
-11,568,000,000 JPY
-18,047,000,000 JPY
Other, net
-144,000,000 JPY
744,000,000 JPY
Net cash provided by (used in) investing activities
-12,444,000,000 JPY
-17,814,000,000 JPY
Cash flows from financing activities
Proceeds from long-term borrowings
16,900,000,000 JPY
25,999,000,000 JPY
Redemption of bonds
-65,000,000 JPY
JPY
Repayments of long-term borrowings
-7,233,000,000 JPY
-3,689,000,000 JPY
Purchase of treasury shares
0 JPY
JPY
Dividends paid
-1,423,000,000 JPY
-1,476,000,000 JPY
Net cash provided by (used in) financing activities
14,203,000,000 JPY
21,129,000,000 JPY
Other, net
22,000,000 JPY
-7,000,000 JPY
Effect of exchange rate change on cash and cash equivalents
971,000,000 JPY
913,000,000 JPY
Net increase (decrease) in cash and cash equivalents
11,384,000,000 JPY
-296,000,000 JPY
Cash and cash equivalents
41,247,000,000 JPY
29,650,000,000 JPY
23,960,000,000 JPY
24,257,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.